Adherence to a Low-Support Cognitive Remediation Training Program for Psychosis.
作者： Rachael Dillon , April Hargreaves , Heike Anderson-Schmidt , Marco Castorina , Aiden Corvin
DOI: 10.1097/NMD.0000000000000557
关键词:
摘要: Cognitive remediation (CR) has emerged as the treatment of choice for impaired cognition in psychosis. However, little is known about adherence rates and factors predicting to CR, particularly clinical settings where high-level therapist support unavailable. This study aimed establish examine variables a computerized CR program psychosis (with minimal support). Patients with (n = 61) participated an 8-week program. Results showed 46% completed meaningful amount training. The fully adherent (>80% prescribed amount) nonadherent groups differed participants had poorer working-memory higher negative symptom scores. These findings suggest that approximately half sample were despite support. Furthermore, cognitive deficits symptoms did not impede adherence, may have contributed patients' motivation complete
sci-hub.se 参考文章(30)
Identifying Modifiable Risk Factors for Rehospitalization: A Case-Control Study of Seriously Mentally Ill Persons in Mississippi American Journal of Psychiatry. ,vol. 152, pp. 1749- 1756 ,(1995) , 10.1176/AJP.152.12.1749
What are the functional consequences of neurocognitive deficits in schizophrenia American Journal of Psychiatry. ,vol. 153, pp. 321- 330 ,(1996) , 10.1176/AJP.153.3.321
April Hargreaves, Rachael Dillon, Heike Anderson-Schmidt, Aiden Corvin, Brian Fitzmaurice, Marco Castorina, IH Robertson, Gary Donohoe, None, Computerised working-memory focused cognitive remediation therapy for psychosis — A preliminary study Schizophrenia Research. ,vol. 169, pp. 135- 140 ,(2015) , 10.1016/J.SCHRES.2015.09.004
T. Wykes, W. D. Spaulding, Thinking About the Future Cognitive Remediation Therapy—What Works and Could We Do Better? Schizophrenia Bulletin. ,vol. 37, ,(2011) , 10.1093/SCHBUL/SBR064
Matthew M. Kurtz, James C. Seltzer, Dana S. Shagan, Warren R. Thime, Bruce E. Wexler, Computer-Assisted Cognitive Remediation in Schizophrenia: What is the Active Ingredient? Schizophrenia Research. ,vol. 89, pp. 251- 260 ,(2007) , 10.1016/J.SCHRES.2006.09.001
Haya Ascher-Svanum, Douglas E. Faries, Baojin Zhu, Frank R. Ernst, Marvin S. Swartz, Jeff W. Swanson, Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. The Journal of Clinical Psychiatry. ,vol. 67, pp. 453- 460 ,(2006) , 10.4088/JCP.V67N0317
Marcia Valenstein, Laurel A. Copeland, Frederic C. Blow, John F. McCarthy, John E. Zeber, Leah Gillon, C. Raymond Bingham, Thomas Stavenger, Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care. ,vol. 40, pp. 630- 639 ,(2002) , 10.1097/00005650-200208000-00002
Michael B. First, The DSM series and experience with DSM-IV. Psychopathology. ,vol. 35, pp. 67- 71 ,(2002) , 10.1159/000065121
MARK D. SULLIVAN, STUART J. YOUNGNER, Drs. Sullivan and Youngner Reply American Journal of Psychiatry. ,vol. 152, pp. 1533- 1533 ,(1995) , 10.1176/AJP.152.10.1533
Mike Startup, Mike C. Jackson, Sue Startup, Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease. ,vol. 194, pp. 740- 745 ,(2006) , 10.1097/01.NMD.0000243081.97879.B9